vaccines

An experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys, a new study shows. The vaccine candidate also protected against infection with an HIV-like virus in monkeys. Based on the results from this phase 1/2a clinical trial that involved nearly 400 healthy adults… Read more

Who likes getting a needle? I know I definitely don’t. Someone else who doesn’t is Mark Kendall from the University of Queensland, winner of the Young Florey Medal 2016. Mark’s work in developing the nanopatch has provided a clear pathway for vaccine delivery science to move beyond 160 year-old needle and syringe technology. What Is… Read more

A rare and improbable mutation in a protein encoded by an influenza virus renders the virus defenseless against the body’s immune system. This University of Rochester Medical Center discovery could provide a new strategy for live influenza vaccines in the future. A new approach to the live flu vaccine would be particularly advantageous right now… Read more

MIT engineers have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks. So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (a relative of the parasite that causes malaria), which were 100 percent effective… Read more

Researchers have developed an E. coli-based transport capsule designed to help next-generation vaccines do a more efficient and effective job than today’s immunizations. The research, described in a study published in the journal Science Advances, highlights the capsule’s success in fighting pneumococcal disease, an infection that can result in pneumonia, sepsis, ear infections and meningitis… Read more